FDA Commissioner Marty Makary has revealed a new priority review voucher programme for new medicines deemed to be of national ...

The Commissioner's National Priority Voucher (CNPV) programme will be available to companies aligned with pressing matters ...

Eli Lilly has confirmed plans for a $1.3 billion takeover bid for Verve Therapeutics, upgrading a collaboration between the ...

FDA Commissioner Dr Martin Makary took the stage at BIO 2025 to detail the way he and his team have been challenging “deeply ...

Factor XIIa inhibitor Andembry (garadacimab) has been cleared in the US for use in patients aged 12 and over with HAE, which ...

The IPO comes just a few weeks after Caris raised $168 million in a private financing round that took the total raised by the ...

Other appointments to BIO's board for the 2025 through 2026 term include: Arcutis Bio's Frank Watanabe, named vice-chair; ...

The Information Commissioner's Office (ICO) has levied a £2.31 million ($3.13 million) penalty on the Californian company in connection with a cyberattack in 2023 that resulted in the personal ...

Dr Lindborg shares her journey to her present role, the true potential shown in this new data for addressing unmet needs in ...

That challenge, of finding or building good, useable data sets, is also one of the biggest differentiators in an increasingly ...

Alpha-1 is a microcosm of the rare disease world. The challenges we face, late diagnoses, inconsistent care, and unaffordable ...

The annual conference of the Biotechnology Innovation Organization (BIO) is always an anticipated gathering where pharma and ...